Thermo Fisher Scientific Inc.
NYSE · Technology · Measuring & Controlling Devices, Nec · Waltham, MA
TMO chart
What traders are saying about $TMO
Latest postsThermo Fisher Scientific Inc. news
- Thermo Fisher Scientific Continues Semiconductor Lab-to-Fab Innovation with Multiple Installations of Optis™ FIB-SEM
Business Wire ·
- Thermo Fisher Scientific (TMO) Stock: $721.63, Up 3.87% Nov 9
JournalArta ·
- Thermo Fisher Scientific Inc (TMO) Stock Up 3.9% but GF Value Sa
GuruFocus ·
- Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.61% on Nov 9: What Signal Does It Send?
TradingKey ·
- 5 Best All-Time High Stocks to Buy According to Wall Street
Yahoo Finance ·
- Thermo Fisher Scientific marks one year in Mebane
News of Orange ·
- Global Genome Annotation Services Market Report 2026: Trends and Forecast to 2030 | Capitalize on AI and Precision Medicine with Roche, Thermo Fisher, Illumina, QIAGEN
Yahoo Finance ·
- Global Clinical Genomics Software Market Report 2026 | Capitalize on 14.8% CAGR Through 2030 as Google, Microsoft, NVIDIA and Illumina Scale AI, Cloud and Precision Medicine
Yahoo Finance ·
- Kinase Drug Discovery Solutions Market Report 2026 | Capture 7.5% CAGR Through 2030 as Thermo Fisher, Eurofins, GenScript, and Sino Biological advance AI and precision oncology
Yahoo Finance ·
- Genomic Variant Prioritization Artificial Intelligence (AI) Global Market Report 2026 | Capitalize on 26.5% CAGR with Illumina, QIAGEN, Thermo Fisher Scientific and Tempus AI
Yahoo Finance ·
- Global Ribonucleic Acid (RNA) Extraction Kits Market Report 2026 | Capitalize on 10.1% CAGR to $3.68B by 2030 as Roche, Thermo Fisher, QIAGEN and Merck Accelerate Automation
Yahoo Finance ·
- Deoxyribonucleic Acid (DNA) Profiling Kits Market Report 2026-2030 | Capitalize on 12.2% CAGR as Thermo Fisher Scientific, Illumina, QIAGEN and Promega Drive NGS, AI and Automation
Yahoo Finance ·
Thermo Fisher Scientific Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $44.56B | $42.88B | $42.86B | $44.91B |
| Net income | $6.72B | $6.34B | $5.96B | $6.96B |
| Diluted EPS | $17.74 | $16.53 | $15.45 | $17.63 |
| Total assets (year end) | $110.34B | $97.32B | $98.73B | $97.15B |
| Cash and equivalents (year end) | $9.85B | $4.01B | $8.08B | $8.52B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Thermo Fisher Scientific Inc.
- Ticker
- TMO (NYSE)
- Industry
- Measuring & Controlling Devices, Nec
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 97745
- Former names
- THERMO ELECTRON CORP
Frequently asked questions
What exchange is Thermo Fisher Scientific Inc. listed on?
Thermo Fisher Scientific Inc. trades on the NYSE under the ticker symbol TMO.
What industry is Thermo Fisher Scientific Inc. in?
Thermo Fisher Scientific Inc. is classified by the SEC under "Measuring & Controlling Devices, Nec", part of the Technology sector on StockTweeting.
Where is Thermo Fisher Scientific Inc. headquartered?
Thermo Fisher Scientific Inc.'s business address on file with the SEC is in Waltham, MA.
When does Thermo Fisher Scientific Inc.'s fiscal year end?
Thermo Fisher Scientific Inc.'s fiscal year ends on December 31.
How much revenue did Thermo Fisher Scientific Inc. report?
Thermo Fisher Scientific Inc. reported $44.56B in revenue for calendar year 2025, according to its SEC filings.